Vutrisiran is an injectable RNA interference (RNAi) therapeutic agent under investigation for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.

If you have a Hayes login, click here to view the full report on the Knowledge Center.